Clinical Trials Logo

Clinical Trial Summary

Total knee arthroplasty is a surgical treatment which involves replacing the damaged articular cartilage of the knee joint with an artificial prosthetic in end-stage knee osteoarthritis. Although total knee arthroplasties are mostly successful, approximately 1 in 5 patients are unsatisfied with their outcomes with 16-33% of patients of patients experiencing lasting pain following total knee arthroplasty. Multiprofen-CC™ is a compounded topical analgesic currently available to healthcare professionals for prescription in patients experiencing localized musculoskeletal pain. To date there has been no evidence-based guidance generated to evaluate the efficacy of Multiprofen-CC™ in osteoarthritis patients. This study will test, in patients with end-stage knee osteoarthritis undergoing total knee arthroplasty, if the use of topical Multiprofen-CC™ in addition to standard of care pain management is more effective in controlling knee pain and reducing opioid use compared to placebo plus standard care alone.


Clinical Trial Description

Total knee replacement, also known as total knee arthroplasty (TKA), is a surgical procedure aimed at alleviating pain and improving joint function in individuals with severe knee joint damage, often caused by conditions like osteoarthritis (OA) While TKAs generally yield positive results, a significant amount of patients express dissatisfaction with their outcomes, with some continuing to experience persistent pain after surgery. Opioids are very commonly prescribed for postsurgical pan, but they can cause a host of unwanted side effects. Orthopaedic surgeons prescribe opioids more frequently than in any other surgical speciality. This is a rising concern to the healthcare system as it may promote the development of opioid use disorder. There is a need for alternative therapies to opioid prescribing in patients having knee surgery to reduce the extensive health risks associated with opioid medications. Multiprofen-CC™ is a multimodal topical cream including ingredients ketoprofen (10%), baclofen (5%), amitriptyline (2%), and lidocaine (5%). Healthcare professionals have the option to prescribe it to patients who are encountering localized musculoskeletal pain. To date there has been no evidence-based guidance generated to evaluate the efficacy of Multiprofen-CC™ in OA patients although there is compelling evidence that its medicinal ingredients are effective in pain relief. The aim of the proposed study is to determine if, in patients with end-stage knee OA undergoing TKA, the use of topical Multiprofen-CC™ in addition to standard of care pain management is more effective in controlling knee pain and reducing opioid use compared to placebo plus standard care alone during a 3 month follow-up period. Secondary objectives include determining the effects of Multiprofen-CC™ compared to placebo on health-related quality of life and satisfaction with pain management, and we will also identify adverse events. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06202989
Study type Interventional
Source KAZM Pharmaceuticals Inc.
Contact Kim Madden, PhD
Phone 289-237-7380
Email maddenk@mcmaster.ca
Status Not yet recruiting
Phase Phase 3
Start date January 2024
Completion date April 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04774328 - Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair Phase 1/Phase 2
Completed NCT03731364 - Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty Phase 2
Recruiting NCT05193227 - Sustained Release Lidocaine for the Treatment of Postoperative Pain Phase 2
Completed NCT01562483 - The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain Phase 2
Completed NCT02081703 - Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Phase 2
Recruiting NCT04647435 - Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction Phase 3
Completed NCT01582477 - TAP-patients With Robotic Assisted Lap Prostatectomy Phase 4
Suspended NCT04681027 - Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children Phase 3
Completed NCT05607641 - Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations Phase 2/Phase 3
Completed NCT01731730 - Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Phase 2
Recruiting NCT05698914 - Telehealth Mindfulness After Spine Surgery N/A
Completed NCT04203537 - Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin) Phase 1/Phase 2
Completed NCT03789318 - Study in Subjects Undergoing Complete Abdominoplasty Phase 2
Completed NCT04648683 - Postoperative Telehealth Mindfulness Intervention After Spine Surgery N/A
Completed NCT06412380 - Influence of Insertion Torque and Bone Type on Post-operative Pain N/A
Recruiting NCT05394402 - A Trial of SHR0410 Injection in Postsurgical Pain Management Phase 2
Not yet recruiting NCT06344169 - Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section Phase 2/Phase 3